FDA Wants New Warnings On Prostate Cancer Drugs

By John Metcalfe · October 20, 2010, 6:32 PM EDT

The U.S. Food and Drug Administration on Wednesday recommended new warning labels for certain prostate cancer drugs sold by Pfizer Inc., Bayer AG and others to inform consumers about the potential...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By John

November 05, 2010
Akzo, AstraZeneca Face 'Dead Peasant' Policy Suit
November 01, 2010
Pfizer Recalls 38,000 More Bottles Of Lipitor
October 29, 2010
Discovery Rule Applies To Stryker Pain Pumps: Judge
October 29, 2010
GSA Subcontractor Pleads Guilty To $1.9M Theft
October 28, 2010
AGA Medical Investor Sues Over $1.3B St. Jude Deal
October 21, 2010
COFC Says Army Health Care Center Contract Flawed
October 13, 2010
FDA To Revise Warning Label On Bone Drugs
October 12, 2010
Man's Pro Se Trademark Battle With 3M Nears End
October 06, 2010
Scientific Image FLSA Lawsuit Will Stay In Calif.
September 24, 2010
Abbott Hit With Class Action Over Bugs In Baby Formula